Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Shire off-loads late-stage ASBT inhibitors to Mirum

Executive Summary

Shire PLC licensed Mirum Pharmaceuticals exclusive global rights to the apical sodium dependent bile acid transporter inhibitors maralixibat (SHP625) and volixibat (SHP626).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R+D and Marketing-Licensing
    • Includes Equity
    • Reverse Licensing

Related Companies

UsernamePublicRestriction

Register